Portfolio Design Labs’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.92M Sell
15,936
-5,582
-26% -$644K 0.34% 56
2025
Q4
$2.27M Buy
21,518
+259
+1% +$24.3K 0.37% 60
2025
Q3
$1.78M Buy
+21,259
New +$1.75M 0.31% 64
2025
Q2
Sell
-42,255
Closed -$3.79M 179
2025
Q1
$3.79M Sell
42,255
-2,262
-5% -$211K 0.78% 40
2024
Q4
$4.43M Buy
44,517
+10,573
+31% +$1.09M 0.91% 25
2024
Q3
$3.85M Buy
33,944
+360
+1% +$42.8K 1.08% 19
2024
Q2
$4.16M Buy
33,584
+3,114
+10% +$401K 1.28% 18
2024
Q1
$4.02M Buy
30,470
+19,817
+186% +$2.44M 1.35% 16
2023
Q4
$1.16M Buy
+10,653
New +$1.11M 0.44% 59

Other funds holding MRK

Portfolio Design Labs's MRK Position: Q1 2026 in Review

Portfolio Design Labs reduced its Merck (MRK) stake by 26% in Q1 2026, selling an estimated $644K and leaving 15,936 shares worth $1.92M. The position accounts for 0.34% of the portfolio, ranked #56.

Portfolio Design Labs first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. The position peaked at $4.43M in Q4 2024. 3,781 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Portfolio Design Labs held 15,936 shares of Merck worth $1.92M as of Q1 2026.
  • Portfolio Design Labs sold 5,582 Merck shares in Q1 2026, an estimated $644K.
  • Merck made up 0.34% of Portfolio Design Labs's portfolio in Q1 2026, its #56 holding.
  • Portfolio Design Labs first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
  • Portfolio Design Labs's Merck position peaked at $4.43M in Q4 2024.
  • 3,781 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Portfolio Design Labs's 13F filing for Q1 2026, filed 11 May 2026.